18.3 C
Tuesday, August 9, 2022

Onconova Therapeutics Inc. (NASDAQ: ONTX) Latest Closing Price Rises

In comparison with $1.56, the latest one-year high, Onconova Therapeutics Inc. (NASDAQ:ONTX) has gone up 24.46% from its recent closing price. In the past five trading sessions, 23.19% of profit have been collected by the stock price of the company. According to a Press Release issued 15years ago, an updated report will be presented by Onconova Therapeutics at the BIO Investor Forum Digital Event, 2020.

Onconova Therapeutics Inc. (NASDAQ :ONTX)- Investment Factors

2.00 is the 36-month value of beta of Onconova Therapeutics Inc. (NASDAQ :ONTX). As per reports, out of the four analysts that issued ratings for the firm’s stock, 0 rated it as ‘buy,’ 0 rated it as ‘overweight,’ 0 rated it as ‘sell,’ and four analysts rated it as ‘hold.’

- Advertisement -

$1.83 is the average price assigned by analysts. 178.68M is Onconova Therapeutics Inc. (NASDAQ :ONTX)’s current public float, and 8.42% of the float is held by the shorts, currently, As of today, 22.18M shares is the average trading volume of the company. As of this week, the stock of Onconova Therapeutics Inc. (NASDAQ :ONTX) climbed 23.19%. Along with that, 48.02% is the monthly jump reported by the firm, -41.78% is the quarterly performance and -60.06% is the firm’s annual rate of performance. For the week, the volatility ratio registered is 8.93%. The volatility ratio for the last 30 days stands at 12.10%. Based on the last 20 days, the simple moving average for Onconova Therapeutics is 19.51%. Based on 200 days, the simple moving average reported by the firm is -30.86%.

Onconova Therapeutics Inc. (NASDAQ:ONTX)- Analysts’ Opinion

Several analysts have issued various comments on Onconova Therapeutics Inc. (NASDAQ :ONTX). H.C. Wainwright has reinstated a ‘buy’ rating to the firm. Based on a research note issued on 1st March 2018, it is estimated that HC Wainwright may set a price of $7.50. 

In a research report issued on 9th October 2019 H.C. Wainwright had issued a ‘buy’ rating to Onconova Therapeutics Inc. along with a price target of $6. 

- Advertisement -

After a market-fall that led ONTX to its low price for the last 52 weeks, the company has been unable to pull back. For the said period, the company registered a loss of -78.44%. 12.10% was the volatility. There was an increase of 8.93% in the volatility rate over the last 30 days. This is because of the rise in shares by +45.14% for the 20-days moving average. As opposed to that, over the last 50 days, the company’s stock is trading at a low of -70.50%; currently.

- Advertisement -

Follow Us


Latest news